1. Volume 51, Issue 2, Pages 366-374 (February 2007)
Overall and Disease-Specific Survival of Patients with Screen-Detected Prostate Cancer in the European Randomized Study of Screening for Prostate Cancer, Section Rotterdam 
Stijn H de Vries, Renske Postma, René Raaijmakers, Stijn Roemeling, Suzie Otto, Harry J. de Koning, Fritz H. Schröder 
European Urology 
Volume 51, Issue 2, Pages (February 2007)
DOI: /j.eururo
Copyright © 2006 European Association of Urology Terms and Conditions

2. Fig. 1
Flow chart for European Randomized Study of Screening for Prostate Cancer (ERSPC), section Rotterdam. Adapted from reference [5].
European Urology  , DOI: ( /j.eururo )
Copyright © 2006 European Association of Urology Terms and Conditions

3. Fig. 2
(A) Observed versus expected overall survival. (B) Comparison of disease-specific survival of the European Randomized Study of Screening for Prostate Cancer (ERSPC) prevalence screen cohort with the observed pCA-specific mortality of Dutch males diagnosed at the age of 60–74 yr during four different time periods [10].
European Urology  , DOI: ( /j.eururo )
Copyright © 2006 European Association of Urology Terms and Conditions

4. Fig. 3
Prostate cancer–specific survival of high-risk prostate cancer patients (n=261).
European Urology  , DOI: ( /j.eururo )
Copyright © 2006 European Association of Urology Terms and Conditions